Clamikalant

Clamikalant is a pharmaceutical compound that has been studied for its potential use in the treatment of cardiac arrhythmias. It is classified as a potassium channel blocker, specifically targeting the IKr channel, which is a component of the cardiac action potential.

Mechanism of Action

Clamikalant works by inhibiting the rapid component of the delayed rectifier potassium current (IKr) in cardiac cells. This action prolongs the repolarization phase of the cardiac action potential, thereby increasing the refractory period of cardiac tissue. By doing so, Clamikalant can help to stabilize the cardiac rhythm and prevent arrhythmias such as atrial fibrillation and ventricular tachycardia.

Pharmacokinetics

The pharmacokinetic profile of Clamikalant includes its absorption, distribution, metabolism, and excretion. Clamikalant is typically administered orally, and it is well-absorbed from the gastrointestinal tract. It is extensively metabolized in the liver, primarily by the cytochrome P450 enzyme system. The elimination half-life of Clamikalant is approximately 6 to 8 hours, and it is excreted primarily via the renal route.

Clinical Uses

Clamikalant has been investigated in clinical trials for its efficacy in treating various types of cardiac arrhythmias. While it shows promise in managing conditions like atrial fibrillation, its use is still under investigation, and it is not yet approved for widespread clinical use.

Side Effects

Common side effects of Clamikalant include dizziness, nausea, and fatigue. More serious adverse effects can include QT interval prolongation, which can lead to Torsades de Pointes, a potentially life-threatening form of ventricular tachycardia.

Research and Development

Ongoing research is focused on optimizing the safety and efficacy of Clamikalant. Studies are being conducted to better understand its pharmacodynamics and to identify patient populations that may benefit the most from its use.

Also see

• Potassium channel blockers
• Cardiac arrhythmia
• Atrial fibrillation
• Ventricular tachycardia

Cardiovascular disease A-Z

Most common cardiac diseases

• Cardiac arrhythmia‎
• Cardiogenetic disorders‎
• Cardiomegaly‎
• Cardiomyopathy‎
• Cardiopulmonary resuscitation‎
• Chronic rheumatic heart diseases‎
• Congenital heart defects‎
• Heart neoplasia‎
• Ischemic heart diseases‎
• Pericardial disorders
• Syndromes affecting the heart‎
• Valvular heart disease‎

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

• Accelerated idioventricular rhythm
• Acute decompensated heart failure
• Arteriosclerotic heart disease
• Athletic heart syndrome
• Atrial flutter
• Atrioventricular fistula
• Cardiovascular disease in Australia
• Autoimmune heart disease

B

• Brown atrophy of the heart

C

• Ebb Cade
• Cardiac allograft vasculopathy
• Cardiac amyloidosis
• Cardiac asthma
• Cardiac tamponade
• Cardiogenic shock
• Cardiogeriatrics
• Cardiorenal syndrome
• Cardiotoxicity
• Carditis
• Coronary artery aneurysm
• Coronary artery anomaly
• Coronary artery disease
• Spontaneous coronary artery dissection
• Coronary artery ectasia
• Coronary occlusion
• Coronary steal
• Coronary thrombosis
• Coronary vasospasm
• Cœur en sabot
• Coxsackievirus-induced cardiomyopathy

D

• Duke Treadmill Score
• Duroziez's disease

E

• Eisenmenger's syndrome
• Embryocardia
• Endocardial fibroelastosis
• Eosinophilic myocarditis

H

• Heart attack
• Heart failure
• Heart failure with preserved ejection fraction
• Heart to Heart (1949 film)
• High-output heart failure
• Hyperdynamic precordium

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

• Idiopathic giant-cell myocarditis
• Interventricular dyssynchrony
• Intraventricular dyssynchrony
• Isolated atrial amyloidosis

K

• Keshan disease

L

• Loeffler endocarditis

M

• Mydicar
• Myocardial bridge
• Myocardial disarray
• Myocardial rupture
• Myocardial scarring
• Myocardial stunning
• Myocarditis

N

• Nonbacterial thrombotic endocarditis

O

• OLR1
• Ostial disease

P

• Papillary fibroelastoma
• Pathophysiology of heart failure
• Postpericardiotomy syndrome
• Pulmonary vein stenosis

R

• Right axis deviation
• Roemheld syndrome

S

• Saturated fat and cardiovascular disease
• SCAR-Fc
• Shone's syndrome
• Strain pattern
• Subacute bacterial endocarditis
• Sudden cardiac death of athletes

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T

• Traumatic cardiac arrest

V

• Ventricular aneurysm
• Vibroacoustic disease
• Viral cardiomyopathy

W

• Waon therapy